US and India-based Genetic diagnostics firm MedGenome Wednesday said it has raised $55 million in a fresh funding round led by global impact investment firm LeapFrog Investments.
Existing investors, Belgium-based Sofina and Sequoia Capital, also participated in the Series D round, MedGenome said in a statement.
